<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>acetylcholinesterase &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/acetylcholinesterase/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 24 Jan 2026 01:26:09 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>acetylcholinesterase &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Coumarin-1,3,4-Oxadiazole Conjugates Target Alzheimer’s Disease</title>
		<link>https://bioengineer.org/coumarin-134-oxadiazole-conjugates-target-alzheimers-disease/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sat, 24 Jan 2026 01:25:46 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[1]]></category>
		<category><![CDATA[3]]></category>
		<category><![CDATA[4-oxadiazole]]></category>
		<category><![CDATA[acetylcholinesterase]]></category>
		<category><![CDATA[Acetylcholinesterase inhibitors]]></category>
		<category><![CDATA[Alzheimer's disease]]></category>
		<category><![CDATA[coumarin]]></category>
		<category><![CDATA[Coumarin-oxadiazole conjugates]]></category>
		<category><![CDATA[Drug design]]></category>
		<category><![CDATA[Dual-targeting ligands]]></category>
		<guid isPermaLink="false">https://bioengineer.org/coumarin-134-oxadiazole-conjugates-target-alzheimers-disease/</guid>

					<description><![CDATA[Alzheimer’s disease poses an increasingly pressing public health challenge, affecting millions worldwide. With an aging population and no available cure, the urgency for effective therapies has intensified. Recent research sheds light on a new class of compounds that may serve as potential dual-targeting ligands to combat this debilitating disease. The innovative study by Arora and [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">320108</post-id>	</item>
	</channel>
</rss>
